CClinicalTrials.gg
CompletedNCT03289845Updated Feb 22, 2018

Clinical Survey of Oticon Medical Ponto BHX Implant

An interventional study of BHX implant (Bone anchored hearing system) in Hearing Impaired (Partially), Hearing Impairment, Conductive and Deafness Unilateral, sponsored by Oticon Medical. Completed at 2 sites in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-02-22.

Sponsored by Oticon Medical · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Investigation of stability of the BHX implant in adult patients indicated and counselled for a bone anchored hearing aid system. Patients are followed according to clinical practice for a total of 12 months in the study. Stability of the implant is evaluated by implant stability quotient.

02

Conditions studied

  • Hearing Impaired (Partially)
  • Hearing Impairment, Conductive
  • Deafness Unilateral
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients eligible for treatment with a bone anchored hearing aid
  • 18 years or older

Exclusion criteria

Exclusion Criteria:

  • Inability to participate in follow-up
  • Diseases or treatments known to compromise the bone quality at the implant site, e.g. radiotherapy, osteoporosis, diabetes mellitus.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
36 participants (actual)

Study arms

  • Other
    BHX implant

    All patients implanted with BHX implant

    Device: BHX implant (Bone anchored hearing system)

Interventions

  • DeviceBHX implant (Bone anchored hearing system)

    Bone anchored hearing system for hearing rehabilitation

05

What researchers measure

Primary outcomes

  1. Implant stability quotient (ISQ) at surgery

    Initial implant stability measured directly after surgery

    Time frame: At surgery

Secondary outcomes

  1. Surgical torque setting measured in Ncm

    The surgical torque setting used to install the implant

    Time frame: At surgery

  2. Possibility to fit the sound processor, yes/no

    Fitting of the sound processor at 5-12 days post-surgery

    Time frame: 5-12 days post surgery

  3. Implant stability quotient (ISQ) after 12 months of follow up

    Long term stability development

    Time frame: 12 months post surgery

  4. Implant survivability measured as percentage successful implants after 12 months

    Implant survivability

    Time frame: 12 months post surgery

06

Study locations

2 sites
  • Dept. of Otolaryngology - Head & Neck Surgery and Audiology, Gentofte/Rigshospitalet,
    Hellerup, Copenhagen 2900, Denmark
  • Department of Oto-Rhino-Laryngology & Audiology Aalborg University Hospital
    Aalborg, Denmark
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03289845
Lead sponsor
Oticon Medical
Responsible party
Sponsor
First posted
Sep 21, 2017
Start date
Nov 5, 2015
Primary completion
Jan 4, 2016
Completion
Dec 2017
Last update
Feb 22, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion